Augmedix Future Growth
Future criteria checks 2/6
Augmedix's earnings are forecast to decline at 2.9% per annum while its annual revenue is expected to grow at 28.4% per year. EPS is expected to grow by 5.3% per annum.
Key information
-2.9%
Earnings growth rate
5.3%
EPS growth rate
| Healthcare Services earnings growth | 27.9% |
| Revenue growth rate | 28.4% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 09 Apr 2024 |
Recent future growth updates
Recent updates
Augmedix, Inc. (NASDAQ:AUGX) Shares Slammed 29% But Getting In Cheap Might Be Difficult Regardless
Apr 25
Augmedix: Secular AI Tailwinds, But Still Unattractive Risk-Reward
Mar 24Augmedix, Inc. (NASDAQ:AUGX) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Nov 09Augmedix reports Q2 results
Aug 08Augmedix: A Splendid Long-Term Investing Opportunity
Jan 21Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 119 | N/A | 3 | N/A | 1 |
| 12/31/2025 | 85 | -20 | -10 | N/A | 5 |
| 12/31/2024 | 61 | -27 | -18 | N/A | 6 |
| 12/31/2023 | 45 | -19 | -19 | -15 | N/A |
| 9/30/2023 | 41 | -20 | -21 | -19 | N/A |
| 6/30/2023 | 37 | -21 | -22 | -20 | N/A |
| 3/31/2023 | 34 | -24 | -20 | -19 | N/A |
| 12/31/2022 | 31 | -24 | -18 | -17 | N/A |
| 9/30/2022 | 29 | -24 | -19 | -18 | N/A |
| 6/30/2022 | 27 | -21 | -21 | -20 | N/A |
| 3/31/2022 | 24 | -19 | -18 | -17 | N/A |
| 12/31/2021 | 22 | -17 | -19 | -19 | N/A |
| 9/30/2021 | 20 | -16 | -18 | -17 | N/A |
| 6/30/2021 | 19 | -17 | -14 | -14 | N/A |
| 3/31/2021 | 17 | -16 | -15 | -14 | N/A |
| 12/31/2020 | 16 | -16 | -15 | -14 | N/A |
| 9/30/2020 | 16 | -15 | -16 | -15 | N/A |
| 6/30/2020 | 15 | -18 | -18 | -17 | N/A |
| 3/31/2020 | 15 | -19 | -18 | -17 | N/A |
| 12/31/2019 | 14 | -18 | -15 | -15 | N/A |
| 12/31/2018 | 11 | -24 | -20 | -20 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AUGX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AUGX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AUGX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AUGX's revenue (28.4% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: AUGX's revenue (28.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AUGX's Return on Equity is forecast to be high in 3 years time